肾移植后三发性甲状旁腺功能亢进:次全切除与全切加自体移植的多中心结局比较
该多中心回顾性研究纳入三发性甲状旁腺功能亢进患者,比较次全甲状旁腺切除术(STPX)与全甲状旁腺切除加自体移植(TPX-A)的结局。在肾移植亚组中,TPX-A 术后甲状旁腺功能减退发生率高于 STPX(45.45% vs 22.95%,P=0.013),长期随访中暂时性和永久性甲状旁腺功能减退率也显著更高(P=0.012);治愈率、持续性和复发性疾病无统计学差异。结论提示对肾移植后三发性甲状旁腺功能亢进患者,STPX 可能是更优选择以避免甲状旁腺功能减退。
要点
- 肾移植后三发性甲旁亢患者中,TPX-A 术后甲状旁腺功能减退发生率高于 STPX。
- 长期随访 TPX-A 的暂时性和永久性甲状旁腺功能减退率均显著高于 STPX。
- 两种术式在治愈率、持续性和复发性甲旁亢方面无统计学差异。
核心结论
- 在肾移植后三发性甲状旁腺功能亢进患者中,STPX 可能是更优术式,可避免甲状旁腺功能减退风险。
研究设计与样本
- 多中心回顾性研究,纳入接受 STPX 或 TPX-A 的三发性甲状旁腺功能亢进患者。
主要发现
- 肾移植组术后随访 TPX-A 甲状旁腺功能减退发生率 45.45%(20 例),STPX 为 22.95%(14 例),P=0.013。
- TPX-A 治愈率 84.09%,STPX 为 73.77%,P=0.153。
- 长期随访 TPX-A 暂时性甲状旁腺功能减退 41.03%(16 例)、永久性 20.51%(8 例);STPX 分别为 17.95%(7 例)和 10.26%(4 例),P=0.012。
- TPX-A 持续性甲旁亢 7.69%(3 例)、复发 5.13%(2 例);STPX 分别为 5.13%(2 例)和 10.26%(4 例),P=0.644。
临床怎么用
- 对肾移植后三发性甲状旁腺功能亢进患者,选择术式时应权衡甲状旁腺功能减退风险,STPX 可能更有利于保留甲状旁腺功能。
局限性
- 回顾性多中心研究设计,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Due to the paucity of data and controversy regarding the preferred surgical approach for managing tertiary HPT, we sought to investigate the outcomes of different surgical approaches in managing this challenging disease. METHODS: We performed a multi-center retrospective study to include patients with tertiary HPT who underwent STPX or total parathyroidectomy with autotransplantation (TPX-A). RESULTS: One hundred five patients had kidney transplant, and 43 were on dialysis. In the kidney transplant group, 61 patients underwent STPX, and 44 for TPX-A. Patients' demographics were not significantly different (48.61 ± 9.31 vs 47.95 ± 12.73 years, P = 0.759. The postoperative follow-up showed that the TPX-A cohort had a higher rate of hypoparathyroidism (N = 20, 45.45%) versus (N = 14, 22.95%) with the STPX cohort (P = 0.013). The cure among the TPX-A cohorts (84.09%) over the STPX cohort (73.77%) (P = 0.153). The long-term follow-up showed that the rate of developing temporary (N = 16, 41.03%) or permanent (N = 8, 20.51%) hypoparathyroidism was significantly higher among patients who underwent TPX-A over the patients who underwent STPX (N = 7, 17.95%), and (N = 4, 10.26%), respectively (P = 0.012). There was no statistical difference between the persistence (N = 3, 7.69%) or the recurrence (N = 2, 5.13%) of the HPT in the TPX-A cohort and the STPX cohort (N = 2, 5.13%). (N = 4, 10.26%), respectively, P = 0.644. CONCLUSIONS: To our knowledge, this is the largest multi-center study that compared different approaches for managing tertiary HPT. Showing that STPX is the better modality in patients diagnosed with tertiary HPT and had kidney transplants avoiding the risk of hypoparathyroidism.
引用
- Choi HR, Aboueisha MA, Attia AS, et al. Outcomes of Subtotal Parathyroidectomy Versus Total Parathyroidectomy With Autotransplantation for Tertiary Hyperparathyroidism: Multi-institutional Study. Ann Surg. 2021. PMID: 34506323. doi:10.1097/SLA.0000000000005059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。